Related references
Note: Only part of the references are listed.Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy
Roberto Sanchez-Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
Ben J. Boyd et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Loading of Porous Functionalized Calcium Carbonate Microparticles: Distribution Analysis with Focused Ion Beam Electron Microscopy and Mercury Porosimetry
Maryam Farzan et al.
PHARMACEUTICS (2019)
Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1
Lenard M. Lichtenberger et al.
CANCER PREVENTION RESEARCH (2017)
Review - An update on the use of oral phospholipid excipients
Peter van Hoogevest
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Self-emulsifying preconcentrates of daidzein-phospholipid complex: design, in vitro and in vivo appraisal
Yosra S. R. Elnaggar et al.
NANOMEDICINE (2017)
Immunosuppressive Medications
Alexander C. Wiseman
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
50 years of oral lipid-based formulations: Provenance, progress and future perspectives
Orlagh M. Feeney et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers
Yehuda Ginosar et al.
ANESTHESIA AND ANALGESIA (2016)
A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic-Pharmacodynamic Studies After Subcutaneous Administration in Pigs
Elyad M. Davidson et al.
ANESTHESIA AND ANALGESIA (2016)
Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view
Bappaditya Chatterjee et al.
DRUG DELIVERY (2016)
Self-emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-cancer genistein: Development, appraisal and ex-vivo intestinal permeation
Eman M. M. Shehata et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Assessing Supersaturation and Its Impact on In Vivo Bioavailability of a Low-Solubility Compound ABT-072 With a Dual pH, Two-Phase Dissolution Method
Yi Shi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Prolonged Analgesic Effect of PRF-108 and PRF-110 on Post-operative Pain in Pigs
David Castel et al.
PAIN AND THERAPY (2016)
Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide
Anuj G. Agrawal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Preparation, characterization and in vivo evaluation of curcumin self-nano phospholipid dispersion as an approach to enhance oral bioavailability
Ahmed N. Allam et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Improved Oral Bioavalability of Mebudipine Upon Administration in PhytoSolve and Phosal-Based Formulation (PBF)
Samira Khani et al.
AAPS PHARMSCITECH (2014)
The use of natural and synthetic phospholipids as pharmaceutical excipients
Peter van Hoogevest et al.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY (2014)
Advent of Novel Phosphatidylcholine-Associated Nonsteroidal Anti-Inflammatory Drugs with Improved Gastrointestinal Safety
Yun Jeong Lim et al.
GUT AND LIVER (2013)
Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's disease
Carol L. Roberts et al.
JOURNAL OF CROHNS & COLITIS (2013)
Transforming Lipid-Based Oral Drug Delivery Systems into Solid Dosage Forms: An Overview of Solid Carriers, Physicochemical Properties, and Biopharmaceutical Performance
Angel Tan et al.
PHARMACEUTICAL RESEARCH (2013)
Pharmacokinetics of the TRPV1 Antagonist ABT-102 in Healthy Human Volunteers: Population Analysis of Data From 3 Phase 1 Trials
Ahmed A. Othman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
Ahmed A. Othman et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2012)
Development and characterization of liquid and solid self-microemulsifying drug delivery system of Tacrolimus
Hitesh K. Patel et al.
ASIAN JOURNAL OF PHARMACEUTICS (2012)
Low-Dose Aspirin-Induced Ulceration Is Attenuated by Aspirin-Phosphatidylcholine: A Randomized Clinical Trial
Byron Cryer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein
Srinivasan Shanmugam et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Drug delivery strategies for poorly water-soluble drugs: the industrial perspective
Peter van Hoogevest et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS)
Srinivasan Shanmugam et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Nanocrystal Technology in the Delivery of Poorly Soluble Drugs: An Overview
Ramesh C. Nagarwal et al.
Current Drug Delivery (2011)
Novel Self-nanoemulsifying Drug Delivery System for Enhanced Solubility and Dissolution of Lutein
Jeoung Hee Yoo et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Gert Fricker et al.
PHARMACEUTICAL RESEARCH (2010)
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2
Matthew A. J. Duncton et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS)
Vikas Agarwal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Effect of the Multitargeted Receptor Tyrosine Kinase Inhibitor, ABT-869 [N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N′-(2-fluoro-5-methylphenyl)urea], on Blood Pressure in Conscious Rats and Mice: Reversal with Antihypertensive Agents and Effect on Tumor Growth Inhibition
Pamela H. Franklin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability
Zhen Ge et al.
ACTA PHARMACOLOGICA SINICA (2008)
Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients
F. L. Lanza et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R. Shoemaker et al.
CLINICAL CANCER RESEARCH (2008)
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management
Arthur Gomtsyan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Low dose lipid formulations: Effects on gastric emptying and biliary secretion
Greg A. Kossena et al.
PHARMACEUTICAL RESEARCH (2007)
Metabolism and pharmacokinetics of a novel Src kinase inhibitor TG100435 ([7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl][4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine) and its active N-oxide metabolite TG100855 ([7-(2,6-dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolidin-1-yl)-ethoxy]phenyl}-amine)
Steven X. Hu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions
EA Coors et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients
FLL Wu et al.
PHARMACOTHERAPY (2005)
The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice
RL Darling et al.
GASTROENTEROLOGY (2004)
Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs
H Tiemessen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Share Paper
